Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017620
Filing Date
2025-06-17
Accepted
2025-06-17 20:10:46
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 form4-06182025_120641.html 4  
1 form4-06182025_120641.xml 4 4253
  Complete submission text file 0001415889-25-017620.txt   6065
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AADI BIOSCIENCE, INC. 17383 SUNSET AVENUE, SUITE A250 PACIFIC PALISADES CA 90272
Business Address
Zhao Baiteng (Reporting) CIK: 0002049287 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 251054861